{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:41:52Z","timestamp":1779345712916,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Meningoencephalomyelitis of unknown etiology (MUE) is a comprehensive term for non-infectious inflammatory brain diseases of the central nervous system (CNS) caused by abnormal autoimmune responses. This study aims to compare the differences in survival and clinical response of MUE according to the adjuvant immunosuppressant use. Medical records of 82 dogs diagnosed with MUE were reviewed retrospectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The overall survival time was 769 days (range 14\u20132687 days). The median survival time for each adjunctive was: leflunomide 1035 days (range 126\u20132163 days), mycophenolate mofetil 865 days (range 39\u20132191 days), cyclosporin 441 days (range 11\u20132176 days), cytosine arabinoside 754 days (range 6\u20131898 days) and a combination of mycophenolate mofetil and cytosine arabinoside 132 days (range 23\u20131227 days). There was no significant difference in the incidence rate of adverse events according to the immunosuppressants, but moderate to severe anemia was confirmed in 3 patients (18.7%) in the leflunomide group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The survival time and response rate of MUE dogs differed depending on which adjunctive immunosuppressants were used. Leflunomide showed a long survival time and a relatively good response rate in dogs with MUE. However, a large-scale further study with standardized doses of immunosuppressants and supportive treatment and constant monitoring interval is needed.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12917-023-03800-3","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T10:02:29Z","timestamp":1702375349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Retrospective evaluation of prognosis and survival with various immunosuppressants in 82 dogs diagnosed with meningoencephalitis of unknown etiology (2010\u20132021)"],"prefix":"10.1186","volume":"19","author":[{"given":"So-Hee","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye-In","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Min","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju Hyun","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Gon","family":"Ah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoung-Won","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwa-Young","family":"Youn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,12]]},"reference":[{"key":"3800_CR1","unstructured":"Schatzberg SJ. An update on granulomatous meningoencephalitis, necrotizing meningoencephalitis and necrotizing leukoencephalitis. Proc 23rd ACvIM. 2005:351\u20133."},{"issue":"12","key":"3800_CR2","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.2460\/javma.1998.212.12.1902","volume":"212","author":"KR Munana","year":"1998","unstructured":"Munana KR, Luttgen PJ. Prognostic factors for dogs with granulomatous meningoencephalomyelitis: 42 cases (1982\u20131996). J Am Vet Med Assoc. 1998;212(12):1902\u20136.","journal-title":"J Am Vet Med Assoc"},{"issue":"3","key":"3800_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1748-5827.2009.00823.x","volume":"51","author":"LR Talarico","year":"2010","unstructured":"Talarico LR, Schatzberg SJ. Idiopathic granulomatous and necrotising inflammatory disorders of the canine central nervous system: a review and future perspectives. J Small Anim Pract. 2010;51(3):138\u201349.","journal-title":"J Small Anim Pract"},{"issue":"3","key":"3800_CR4","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.tvjl.2009.03.031","volume":"184","author":"N Granger","year":"2010","unstructured":"Granger N, Smith PM, Jeffery ND. Clinical findings and treatment of non-infectious meningoencephalomyelitis in dogs: a systematic review of 457 published cases from 1962 to 2008. Vet J. 2010;184(3):290\u20137.","journal-title":"Vet J"},{"issue":"6","key":"3800_CR5","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.cvsm.2014.07.009","volume":"44","author":"JR Coates","year":"2014","unstructured":"Coates JR, Jeffery ND. Perspectives on meningoencephalomyelitis of unknown origin. Vet Clin North Am Small Anim Pract. 2014;44(6):1157\u201385.","journal-title":"Vet Clin North Am Small Anim Pract"},{"issue":"10","key":"3800_CR6","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/j.1748-5827.2006.00172.x","volume":"47","author":"M Zarfoss","year":"2006","unstructured":"Zarfoss M, Schatzberg S, Venator K, Cutter-Schatzberg K, Cuddon P, Pintar J, et al. Combined cytosine arabinoside and prednisone therapy for meningoencephalitis of unknown aetiology in 10 dogs. J Small Anim Pract. 2006;47(10):588\u201395.","journal-title":"J Small Anim Pract"},{"key":"3800_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tvjl.2016.03.026","volume":"213","author":"M Lowrie","year":"2016","unstructured":"Lowrie M, Thomson S, Smith P, Garosi L. Effect of a constant rate infusion of cytosine arabinoside on mortality in dogs with meningoencephalitis of unknown origin. Vet J. 2016;213:1\u20135.","journal-title":"Vet J"},{"issue":"9","key":"3800_CR8","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/j.1748-5827.2006.00303.x","volume":"48","author":"PF Adamo","year":"2007","unstructured":"Adamo PF, Rylander H, Adams WM. Ciclosporin use in multi-drug therapy for meningoencephalomyelitis of unknown aetiology in dogs. J Small Anim Pract. 2007;48(9):486\u201396.","journal-title":"J Small Anim Pract"},{"issue":"8","key":"3800_CR9","doi-asserted-by":"publisher","first-page":"929","DOI":"10.2460\/javma.237.8.929","volume":"237","author":"MA Wong","year":"2010","unstructured":"Wong MA, Hopkins AL, Meeks JC, Clarke JD. Evaluation of treatment with a combination of azathioprine and prednisone in dogs with meningoencephalomyelitis of undetermined etiology: 40 cases (2000\u20132007). J Am Vet Med Assoc. 2010;237(8):929\u201335.","journal-title":"J Am Vet Med Assoc"},{"issue":"1","key":"3800_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12917-020-02414-3","volume":"16","author":"J-H Song","year":"2020","unstructured":"Song J-H, Yu D-H, Lee H-C, Hwang T-S, Kim YJ, An S-J, et al. Evaluation of treatment with a combination of mycophenolate mofetil and prednisolone in dogs with meningoencephalomyelitis of unknown etiology: a retrospective study of 86 cases (2009\u20132017). BMC Vet Res. 2020;16(1):1\u201312.","journal-title":"BMC Vet Res"},{"issue":"1","key":"3800_CR11","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/vec.12399","volume":"26","author":"I Barnoon","year":"2016","unstructured":"Barnoon I, Shamir MH, Aroch I, Bdolah-Abram T, Srugo I, Konstantin L, et al. Retrospective evaluation of combined mycophenolate mofetil and prednisone treatment for meningoencephalomyelitis of unknown etiology in dogs: 25 cases (2005\u20132011). J Veterinary Emerg Crit Care. 2016;26(1):116\u201324.","journal-title":"J Veterinary Emerg Crit Care"},{"issue":"3","key":"3800_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1136\/vr.164.3.89","volume":"164","author":"A Pakozdy","year":"2009","unstructured":"Pakozdy A, Leschnik M, Kneissl S, Gumpenberger S, Gruber A, Tichy A, et al. Improved survival time in dogs with suspected GME treated with ciclosporin. Vet Rec. 2009;164(3):89\u201390.","journal-title":"Vet Rec"},{"issue":"12","key":"3800_CR13","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1292\/jvms.69.1303","volume":"69","author":"DI Jung","year":"2007","unstructured":"Jung DI, Kang BT, Park C, Yoo JH, Gu SH, Jeon HW, et al. A comparison of combination therapy (cyclosporine plus prednisolone) with sole prednisolone therapy in 7 dogs with necrotizing meningoencephalitis. J Vet Med Sci. 2007;69(12):1303\u20136.","journal-title":"J Vet Med Sci"},{"issue":"5","key":"3800_CR14","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1111\/jvim.14810","volume":"31","author":"M Sato","year":"2017","unstructured":"Sato M, Veir J, Legare M, Lappin M. A retrospective study on the safety and efficacy of leflunomide in dogs. J Vet Intern Med. 2017;31(5):1502\u20137.","journal-title":"J Vet Intern Med"},{"issue":"8","key":"3800_CR15","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1016\/S0041-1345(98)01373-6","volume":"30","author":"CR Gregory","year":"1998","unstructured":"Gregory CR, Stewart A, Sturges B, DeManvelle T, Cannon A, Ortega T, et al. Leflunomide effectively treats naturally occurring immune-mediated and inflammatory Diseases of dogs that are unresponsive to conventional therapy. Transpl Proc. 1998;30(8):4143\u201348.","journal-title":"Transpl Proc"},{"issue":"5","key":"3800_CR16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1748-5827.1989.tb01558.x","volume":"30","author":"J Thomas","year":"1989","unstructured":"Thomas J, Eger C. Granulomatous meningoence-phalomyelitis in 21 dogs. J Small Anim Pract. 1989;30(5):287\u201393.","journal-title":"J Small Anim Pract"},{"issue":"15","key":"3800_CR17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/vr.148.15.467","volume":"148","author":"S Demierre","year":"2001","unstructured":"Demierre S, Vandevelde M, Jaggy A, Griot-Wenk M, Welle M, Tippold A. Correlation between the clinical course of granulomatous meningoencephalomyelitis in dogs and the extent of mast cell infiltration. Vet Rec. 2001;148(15):467\u201372.","journal-title":"Vet Rec"},{"issue":"4","key":"3800_CR18","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1111\/j.1939-1676.2008.0137.x","volume":"22","author":"J Levine","year":"2008","unstructured":"Levine J, Fosgate G, Porter B, Schatzberg S, Greer K. Epidemiology of necrotizing meningoencephalitis in pug dogs. J Vet Intern Med. 2008;22(4):961\u20138.","journal-title":"J Vet Intern Med"},{"issue":"4","key":"3800_CR19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1136\/vr.159.4.110","volume":"159","author":"G Cherubini","year":"2006","unstructured":"Cherubini G, Platt S, Anderson T, Rusbridge C, Lorenzo V, Mantis P, et al. Characteristics of magnetic resonance images of granulomatous meningoencephalomyelitis in 11 dogs. Vet Rec. 2006;159(4):110\u20135.","journal-title":"Vet Rec"},{"issue":"2","key":"3800_CR20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4103\/0976-3147.112737","volume":"4","author":"D Joshi","year":"2013","unstructured":"Joshi D, Kundana K, Puranik A, Joshi R. Diagnostic accuracy of urinary reagent strip to determine cerebrospinal fluid chemistry and cellularity. J Neurosci Rural Pract. 2013;4(2):140\u20135.","journal-title":"J Neurosci Rural Pract"},{"issue":"1","key":"3800_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.tvjl.2014.04.020","volume":"201","author":"S Bittermann","year":"2014","unstructured":"Bittermann S, Lang J, Henke D, Howard J, Gorgas D. Magnetic resonance imaging signs of presumed elevated intracranial pressure in dogs. Vet J. 2014;201(1):101\u20138.","journal-title":"Vet J"},{"issue":"20","key":"3800_CR22","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1136\/vr.101431","volume":"172","author":"M Lowrie","year":"2013","unstructured":"Lowrie M, Smith P, Garosi L. Meningoencephalitis of unknown origin: investigation of prognostic factors and outcome using a standard treatment protocol. Vet Rec. 2013;172(20):527.","journal-title":"Vet Rec"},{"issue":"6","key":"3800_CR23","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1365-2885.2011.01275.x","volume":"34","author":"L Singer","year":"2011","unstructured":"Singer L, Cohn L, Reinero C, Papich M. Leflunomide pharmacokinetics after single oral administration to dogs. J Vet Pharmacol Ther. 2011;34(6):609\u201311.","journal-title":"J Vet Pharmacol Ther"},{"issue":"3","key":"3800_CR24","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/j.1939-1676.2009.0299.x","volume":"23","author":"PM Smith","year":"2009","unstructured":"Smith PM, Stalin CE, Shaw D, Granger N, Jeffery ND. Comparison of two regimens for the treatment of meningoencephalomyelitis of unknown etiology. J Vet Intern Med. 2009;23(3):520\u20136.","journal-title":"J Vet Intern Med"},{"issue":"1","key":"3800_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/00007890-199601150-00018","volume":"61","author":"LJ Langman","year":"1996","unstructured":"Langman LJ, Shapiro AMJ, Lakey JRT, LeGatt DF, Kneteman NM, Yatscoff RW. Phamacodynamic assessment of mycophenolic acid-induced immunosuppression by measurement of inosine monophosphate dehydrogenase activity in a canine model. Transplantation. 1996;61(1):87\u201392.","journal-title":"Transplantation"},{"issue":"3","key":"3800_CR26","doi-asserted-by":"publisher","first-page":"829","DOI":"10.2215\/CJN.03930907","volume":"3","author":"N Leca","year":"2008","unstructured":"Leca N, Muczynski KA, Jefferson JA, De Boer IH, Kowalewska J, Kendrick EA, et al. Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients. Clin J Am Soc Nephrol. 2008;3(3):829\u201335.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"3800_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.12793\/jkscpt.2008.16.2.87","volume":"16","author":"SY Park","year":"2008","unstructured":"Park SY, Back SY, Park SW, Kim JH, Son CN, Cho SK, Bae KI. Hemolytic Anemia in a patient with rheumatoid arthritis treated with Leflunomide. J Korean Soc Clin Pharmacol Ther. 2008;16(2):87\u201390.","journal-title":"J Korean Soc Clin Pharmacol Ther"},{"issue":"12","key":"3800_CR28","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1097\/00007890-199457120-00005","volume":"57","author":"LP McChesney","year":"1994","unstructured":"McChesney LP, Xiao F, Sankary HN, Foster PF, Sharma S, Haklin M, et al. An evaluation of leflunomide in the canine renal transplantation model. Transplantation. 1994;57(12):1717\u201322.","journal-title":"Transplantation"},{"issue":"2","key":"3800_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/vms3.22","volume":"2","author":"AD Woolcock","year":"2016","unstructured":"Woolcock AD, Wang A, Haley A, Kent M, Creevy KE, Platt SR. Treatment of canine meningoencephalomyelitis of unknown aetiology with mycophenolate mofetil and corticosteroids: 25 cases (2007\u20132012). Veterinary Med Sci. 2016;2(2):125\u201335.","journal-title":"Veterinary Med Sci"},{"issue":"1","key":"3800_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/BF00686329","volume":"29","author":"JCR Scott-Moncrieff","year":"1991","unstructured":"Scott-Moncrieff JCR, Chan TC, Samuels ML, Cook JR, Coppoc GL, DeNicola DB, et al. Plasma and cerebrospinal fluid pharmacokinetics of cytosine arabinoside in dogs. Cancer Chemother Pharmacol. 1991;29(1):13\u20138.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"8","key":"3800_CR31","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/vr.162.8.241","volume":"162","author":"P Menaut","year":"2008","unstructured":"Menaut P, Landart J, Behr S, Lanore D, Trumel C. Treatment of 11 dogs with meningoencephalomyelitis of unknown origin with a combination of prednisolone and cytosine arabinoside. Vet Rec. 2008;162(8):241\u20135.","journal-title":"Vet Rec"},{"issue":"1","key":"3800_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.tvjl.2007.11.024","volume":"180","author":"R Di Terlizzi","year":"2009","unstructured":"Di Terlizzi R, Platt SR. The function, composition and analysis of cerebrospinal fluid in companion animals: part II\u2013analysis. Vet J. 2009;180(1):15\u201332.","journal-title":"Vet J"},{"issue":"4","key":"3800_CR33","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/jvp.12360","volume":"40","author":"P Early","year":"2017","unstructured":"Early P, Crook K, Williams L, Davis E, Mu\u00f1ana K, Papich M, et al. Plasma and serum concentrations of cytarabine administered via continuous intravenous infusion to dogs with meningoencephalomyelitis of unknown etiology. J Vet Pharmacol Ther. 2017;40(4):411\u20134.","journal-title":"J Vet Pharmacol Ther"},{"issue":"11","key":"3800_CR34","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1136\/vr.106019","volume":"187","author":"K Stee","year":"2020","unstructured":"Stee K, Broeckx BJ, Targett M, Gomes SA, Lowrie M. Cytosine arabinoside constant rate infusion without subsequent subcutaneous injections for the treatment of dogs with meningoencephalomyelitis of unknown origin. Vet Rec. 2020;187(11):e98.","journal-title":"Vet Rec"},{"issue":"5","key":"3800_CR35","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/jvp.12667","volume":"41","author":"B Pastina","year":"2018","unstructured":"Pastina B, Early P, Bergman R, Nettifee J, Maller A, Bray K, et al. The pharmacokinetics of cytarabine administered subcutaneously, combined with prednisone, in dogs with meningoencephalomyelitis of unknown etiology. J Vet Pharmacol Ther. 2018;41(5):638\u201343.","journal-title":"J Vet Pharmacol Ther"},{"issue":"5","key":"3800_CR36","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/jvp.12980","volume":"44","author":"HA Levitin","year":"2021","unstructured":"Levitin HA, Foss KD, Li Z, Reinhart JM, Hague DW, Fan TM. Pharmacokinetics of a cytosine arabinoside subcutaneous protocol in dogs with meningoencephalomyelitis of unknown aetiology. J Vet Pharmacol Ther. 2021;44(5):696\u2013704.","journal-title":"J Vet Pharmacol Ther"},{"issue":"1","key":"3800_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jvim.12265","volume":"28","author":"T Archer","year":"2014","unstructured":"Archer T, Boothe D, Langston V, Fellman C, Lunsford K, Mackin A. Oral cyclosporine treatment in dogs: a review of the literature. J Vet Intern Med. 2014;28(1):1\u201320.","journal-title":"J Vet Intern Med"},{"issue":"2","key":"3800_CR38","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/jvim.15441","volume":"33","author":"OA Garden","year":"2019","unstructured":"Garden OA, Kidd L, Mexas AM, Chang YM, Jeffery U, Blois SL, et al. ACVIM consensus statement on the diagnosis of immune-mediated hemolytic anemia in dogs and cats. J Vet Intern Med. 2019;33(2):313\u201334.","journal-title":"J Vet Intern Med"},{"issue":"Suppl 1","key":"3800_CR39","first-page":"60","volume":"27","author":"IGDS Group","year":"2013","unstructured":"Group IGDS, Goldstein RE, Brovida C, Fernandez-Del Palacio MJ, Littman MP, Polzin DJ, et al. Consensus recommendations for treatment for dogs with serology positive glomerular Disease. J Vet Intern Med. 2013;27(Suppl 1):60\u20136.","journal-title":"J Vet Intern Med"},{"issue":"2","key":"3800_CR40","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/vco.12677","volume":"19","author":"AK LeBlanc","year":"2021","unstructured":"LeBlanc AK, Atherton M, Bentley RT, Boudreau CE, Burton JH, Curran KM, et al. Veterinary Cooperative Oncology Group-Common Terminology Criteria for adverse events (VCOG-CTCAE v2) following investigational therapy in dogs and cats. Vet Comp Oncol. 2021;19(2):311\u201352.","journal-title":"Vet Comp Oncol"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-023-03800-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-023-03800-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-023-03800-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T20:21:42Z","timestamp":1730838102000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-023-03800-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,12]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3800"],"URL":"https:\/\/doi.org\/10.1186\/s12917-023-03800-3","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,12]]},"assertion":[{"value":"22 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm that all methods were carried out in accordance with the ARRIVE guidelines as applicable. This study reviewed the medical records from privately-owned dogs, all receiving care as prescribed by licensed veterinarians. If information on the survival status was needed in patients who did not follow-up, a telephone interview with the owner was used and oral informed consent was obtained for the use of patient data. In Korea, in accordance with the Enforcement Rules of the Bioethics and Safety Act, the research that does not collect or record personal identification and uses existing data or documents on research subjects, can be exempted from deliberation by the institutional review board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. The retrospective study described here involved review of medical records from privately-owned dogs, all receiving cares as prescribed by licensed veterinarians. Under such circumstances, no formal review by an Institutional Animal Care and Use Committee is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"269"}}